Skip to main content
. 2017 Aug 30;7:9938. doi: 10.1038/s41598-017-09275-1

Figure 1.

Figure 1

Identification of HNO-modified cysteines in PKGIα by NOxICAT. (A) Exposure of recombinant human PKGIα to HNO donors induced oxidation of Cys42, Cys117 and Cys195 in PKGIα. The table summarises the mass charge (m/z) in molecular ions (mi) of the detected peptides containing the cysteines in the reduced (blue) and oxidised (pink) state. (B) Fourier Transform Mass Spectrometry spectra are expressed as the relative abundance of the detected peptides in m/z containing Cys42 (left), Cys117 (middle) and Cys195 (right), vehicle-treated (top), after exposure to 1-nitrosocyclohexyl acetate (NCA; 25 mmol/L, 15 min) (middle) or Angeli’s salt (AS; 25 µmol/L, 15 min) (bottom). (C) Quantification of the detected oxidised (pink) versus reduced (blue) peptide fraction is shown as percent of the total detected peptides.